It is currently Sun Nov 29, 2015 3:12 pm

News News of Tysabri (Antegren or Natalizumab)

Site map of Tysabri (Antegren or Natalizumab) » Forum : Tysabri (Antegren or Natalizumab)

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Tysabri Free Webcast Hosts Free Patient Webcast on Multiple Sclerosis and the FDA's Reapproval of Tysabri June 22nd, 8:30 PM (Eastern)

Program to Feature Prominent MS Experts Discussing the Drug and What It Means for Consumers

SEATTLE, June 15 /PRNewswire/ --

WHAT: HealthTalk Inc., a pioneer in patient education delivering live
and web-based programs on the latest treatments and research
news, is hosting a live webcast for Multiple Sclerosis
patients, their families and caregivers. Experts will be ...
Read more : Tysabri Free Webcast | Views : 1489 | Replies : 0

Tysabri Q&As

Read more : Tysabri Q&As | Views : 1871 | Replies : 0

It's BACK!!!!!!!!

US OKs resumed sales of Biogen and Elan's Tysabri

WASHINGTON (Reuters) - Biogen Idec Inc. and Elan Corp. won permission on Monday to resume sales of their multiple sclerosis drug Tysabri, which was withdrawn last year after it was linked to a rare but potentially fatal brain disease, U.S. regulators said.

The U.S. Food and Drug Administration said Tysabri must be sold under a restricted distribution plan to minimize chances of harm. Tysabri should be ...
Read more : It's BACK!!!!!!!! | Views : 2052 | Replies : 6

Tysabri back soon

The Sunday Times says that Tysabri might get FDA approval this week.

Sorry to spoil you Sunday lunch HarryZ :lol: Perhaps you could turn your attention to Rituxan or Dacluzimab.

The article says that Tysabri will be $23,000 a year. About as much as Harry takes each month from the dividends from his Biogen shares. :lol:


Read more : Tysabri back soon | Views : 1511 | Replies : 1


One for you HarryZ - UK MS Society presentation on Tysabri

Read more : Presentation | Views : 1827 | Replies : 3

Tysabri approved in EU

Just something i stumbled across this morning

The EU's CHMP has recommended approval of Elan and Biogen Idec's Tysabri (natalizumab), as a monotherapy for multiple sclerosis.

The product, which was launched in the US in late 2004 and voluntarily suspended two months later, has been given the go-ahead in the EU for use to delay the progression of disability and reduce the frequency of relapses in patients with high disease activity despite treatment with a ...
Read more : Tysabri approved in EU | Views : 1533 | Replies : 0

EU recommends restricted availability

Recommendations on Tysabri release restriction

28 April 2006 11:56

The European Medicines Agency (EMA) has recommended that the multiple sclerosis treatment drug, Tysabri, should be made available to patients on a restricted basis.

Tysabri was withdrawn from the market early in 2005 after some US patients who had been treated with the drug in combination with other medication developed the brain disease, PML.

The decision led to the collapse of Élan's share price.

Since then ...
Read more : EU recommends restricted availability | Views : 1444 | Replies : 1


Login  •  Register


Total posts 228634 • Total topics 24190 • Total members 15483

Contact us | Terms of Service